Earlier this week, it was reported that Neil Magny was forced to withdraw from his match-up against Vicente Luque at UFC Rochester. The welterweight has finally revealed the reasoning why and apparently it stems from a failed USADA test. In his statement, Magny first apologizes to fans and confirms that on the 11
th, he received an email from USADA stating that he failed an “out of competition drug test due to the banned substance “Di-Hydroxy-LGD-4033”.
LGD-4033 is listed as an anabolic agent according to the World Anti-Doping Agency’s prohibited list, which has been adopted by the USADA. It is prohibited year-round. He doesn’t go into deeper details about the situation, but does note that he working with USADA to determine how the substance was found in his testing.
Derrick Krantz has replaced the welterweight and will be fighting Vicente Luque this Saturday at UFC Rochester.
As many of you know, I had to withdraw from my sceduled bout against Vicente Luque on Saturday, May 18th. I want to apologize to him, as I know how difficult it is to lose an opponent days out from a fight. Throughout my MMA career I have been very transparent. I am not afraid to admit when I am in the wrong. On Saturday, May 11, 2019, I recieved an email from USADA stating that I have been flagged due to an "out of competition drug test". The flag was due to a metabolite of the substance "Di-Hydroxy-LGD-4033". I have fully cooperated with USADA thus far to determine how this substance was found in the sample I provided them on May 5, 2019. I have always been an advocate for the strict drug testing in the UFC, even to the extent of opting for my collected samples to be used for research purposes by USADA. I know without a doubt that I have done everything according to the standards set by USADA. I have faith in USADA that this situation will resolved in a timely manner and that I will be cleared of any wrong doing. To all of my fans and supporters, thank you. I assure you that I have not let you down.
A post shared by Neil Magny (@neil_magny170) on